Page last updated: 2024-08-23

pefloxacin and Bone Loss, Osteoclastic

pefloxacin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, EK; Donatelli, RE; Haroun, IN; Harris, A; Holliday, LS; Magis, AT; Nagib, MI; Ostrov, DA; Piedrahita, A; Sajek, K; Toro, EJ; Wronski, TJ	1

Other Studies

1 other study(ies) available for pefloxacin and Bone Loss, Osteoclastic

Article	Year
Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening. Journal of medicinal chemistry, 2009, Aug-27, Volume: 52, Issue:16 Topics: Actin Cytoskeleton; Actins; Animals; Binding Sites; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Enoxacin; In Vitro Techniques; Mice; Models, Molecular; Osteoclasts; Protein Binding; Protein Subunits; Quantitative Structure-Activity Relationship; Vacuolar Proton-Translocating ATPases	2009

Article

Year

Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.

Journal of medicinal chemistry, 2009, Aug-27, Volume: 52, Issue:16

Topics: Actin Cytoskeleton; Actins; Animals; Binding Sites; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Enoxacin; In Vitro Techniques; Mice; Models, Molecular; Osteoclasts; Protein Binding; Protein Subunits; Quantitative Structure-Activity Relationship; Vacuolar Proton-Translocating ATPases

2009